Separating and purifying method for new recombinant human interferon alpha2b

A technology for the separation and purification of recombinant human interferon, applied in the field of separation and purification of recombinant human interferon α2b, can solve the problems of difficult separation and purification, many separation and purification steps, poor pressure resistance of chromatographic media, etc., and achieve the effect of smooth process flow

Active Publication Date: 2006-03-22
BEIJING KAWIN TECH SHARE HLDG
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] For this purpose, the existing industrialized production techniques of recombinant human interferon α2b all adopt processes such as salting-out and ultrafiltration desalination, salt concentration gradient elution and dialysis, and their common problems are: (1) low renaturation efficiency : The traditional dilution renaturation method dilutes the sample tens of times or even hundreds of times, which will increase the volume of the sample sharply, which brings great difficulties to the subsequent separation and purification, and requires a large amount of renaturation during the renaturation process container; dialysis is time-consuming and requires multiple changes of dialysis solution
The common disadvantage of these two methods is that the protein will aggregate during the renaturation process and produce a large amount of precipitation, the renaturation efficiency is low, the activity recovery rate of the protein is usually only 5-20%, and the protein solution after renaturation contains a large amount of Miscellaneous proteins need to be further separated and purified; (2) The process route is cumbersome and the production cycle is long: In the traditional separation and purification process of recombinant proteins, most of the classic soft gel separation media are used. Due to the large particles of this medium, The separation efficiency is poor, so it is often necessary to use a variety of different modes of chromatographic operations to purify the target protein in order to obtain the target protein with a purity that meets a certain standard
In addition, the pressure resistance of this chromatographic medium is very poor, and it can only be operated at a low flow rate, and the separation and purification time is long; the separation and purification steps and the long separation time make the mass recovery rate and activity recovery rate of the protein very low. low; and in the traditional recombinant protein production process, protein renaturation and purification are two independent unit operations in the production process, which also restricts production efficiency to a large extent; (3) high production costs and large investment in equipment : Because refolding and separation and purification are carried out separately, and there are many separation and purification steps, each step needs to have matching equipment, resulting in large equipment investment and high production cost. With the increase of production scale, this drawback will become more and more serious. more serious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] primary interferon

[0028] 1. TE washing

[0029] Take out the cells, dissolve them quickly in running water, add pre-cooled TE solution, stir well, centrifuge at 4000 rpm at 4°C for 20 minutes, discard the supernatant and keep the precipitate.

[0030] 2. Ultrasonic bacteria destruction:

[0031] Put the suspended bacterial solution in an ice bath environment, 1 minute / time, with an interval of 1 minute, and sonicate 25-30 times. Microscopic examination, the bacteria destruction rate should be greater than 98%. Add the pre-cooled TE solution according to the weight of the engineered bacteria at a ratio of 1:5 (weight / volume), stir well, centrifuge at 10,000 rpm at 4°C for 20 minutes, discard the supernatant, and weigh the precipitate.

[0032] 3. Urea dissolution:

[0033] Add the precipitate to the pre-cooled 4M urea / TE solution at a ratio of 1:10 (weight / volume), pipette evenly, centrifuge at 10,000 rpm at 4°C for 25 minutes, discard the supernatant and save the...

Embodiment 2

[0090] This clinical trial proves that the safety and anti-HBV curative effect of the recombinant human interferon α2b for injection developed by this process are equivalent to those produced by the original process. There is no significant difference in curative effect between the two, and both have good safety.

[0091] The clinical protocol and data are as follows:

[0092] In this study, a multi-center, randomized double-blind, positive drug parallel control test method was adopted. The recombinant human a-2b interferon for injection produced by the original technology of Beijing Kaiyin Biotechnology Co., Ltd. was used as a control to evaluate the company's new technology. Safety and efficacy of recombinant human alpha-2b interferon for injection in the treatment of HBeAg-positive chronic hepatitis B patients. There were 225 cases in the ITT population, 20 cases dropped out, and the drop-out rate was 8.88%. There were 205 cases in the PP population, of which 205 cases (91....

Embodiment 3

[0100] This stability test confirms that the stability of the product produced by the process of the present invention meets the quality requirements.

[0101] method:

[0102] 1. Stability key inspection items: appearance, solubility, clarity, biological activity, pH value of the finished product

[0103] Other testing items: sterility test, moisture.

[0104] (1) Measuring methods for appearance, solubility and clarity of finished products: see Appendix IX A and B of the Pharmacopoeia of the People's Republic of China and Regulations for Biological Products of China

[0105] (2) Biological activity assay method: Cytopathic inhibition method, Wish cell / VSV as detection system. Calibrated with national reference standards.

[0106] (3) pH value determination method: see "Pharmacopoeia of the People's Republic of China" Appendix VI H

[0107] (4) Sterility test: refer to item A of the general rule "Biological Products Sterility Test Regulations" of "China Regulations for Biol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to the separation and purification method of new recombinant human interferon alpha-2b. The separation and purification method includes the following steps: crushing recombinant human interferon alpha-2b colibacillus as engineering bacillus, dissolving in urea solution, Tris-HCl washing, cracking with guanidine hydrochloride, boric acid renaturing, regulating pH value, dissolving in salt solution, chromatographic separation with hydrophobic column M1, chromatographic separation with CM-Sepharose column, chromatographic separation with hydrophobic column M2, and chromatographic separation with S-100 molecular sieve. The present invention has less purification steps and integrated purification process, and may be used in large scale automatic production.

Description

technical field [0001] The invention relates to a method for splitting and purifying biological proteins, and more specifically, relates to a novel method for separating and purifying recombinant human interferon alpha 2b. Background technique [0002] Recombinant human interferon α2b has the functions of broad-spectrum anti-virus, anti-tumor, inhibiting cell proliferation and improving immune function. The combination of interferon and cell surface receptors induces cells to produce a variety of antiviral proteins, inhibits virus reproduction in cells, and improves immune function, including enhancing the phagocytosis of macrophages, enhancing the cytotoxicity and natural killing of lymphocytes to target cells cell function. [0003] The purification methods of recombinant human interferon α2b reported in the literature mainly fall into two categories, affinity chromatography and non-affinity chromatography. The purity of the recombinant human interferon α2b obtained by a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/56C07K1/14
Inventor 张春丽
Owner BEIJING KAWIN TECH SHARE HLDG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products